ECO Animal Health Group
EAH · AIM · Health Care · mcap £65m · 95.5p
Directors
purchase David Hallas, Chief Executive Officer of Eco Animal Health Group plc, purchased 18,348 ordinary shares at 109 pence per share on December 4, 2025. Following this transaction, Mr. Hallas now holds 203,041 ordinary shares, 4 Dec 2025
award Eco Animal Health Group plc announced that Chief Financial Officer Christopher Wilks exercised 4,309 nominal cost share options, which were satisfied by transferring existing ordinary shares from the Employee Benefit Tru 18 Dec 2025
other ECO Animal Health Group plc announces that Independent Non-Executive Director Frank Armstrong will step down following the Annual General Meeting, anticipated in September. Dr. Armstrong is retiring from his position due 31 Mar 2026
purchase David Hallas, Chief Executive Officer of Eco Animal Health Group PLC, purchased 22,346 ordinary shares at 89.5 pence per share on 16 July 2026, increasing his total holding to 225,387 shares, which represents approximate 16 Jul 2026
other ECO Animal Health Group plc announced the immediate appointment of Dr. Didier Branellec as an Independent Non-Executive Director, bringing over two decades of international experience in life sciences, corporate strategy 8 Sep 2026
award Eco Animal Health Group plc announced on September 9, 2026, that conditional share options and restricted share units were granted to its Executive Directors under the Long Term Incentive Plan. The Chief Executive Office 11 Sep 2026
Company filings. Not investment advice.